5 Key Takeaways

• 1

  The study on MDMA-assisted psychotherapy for PTSD was retracted due to protocol violations at one study site.

• 2

  Researchers failed to disclose these violations or remove compromised data from their analysis.

• 3

  The study reported significant long-term reductions in PTSD symptoms, with 67% of participants no longer meeting diagnostic criteria.

• 4

  Several authors had conflicts of interest related to the Multidisciplinary Association for Psychedelic Studies (MAPS), which funded the study.

• 5

  The retraction highlights the need for ethical compliance and transparency in research, raising concerns about the study's validity.